Category: Right to Try

THE NATION’S FIRST LEGAL CHALLENGE TO ALLOW PSILOCYBIN THERAPY IN END-OF-LIFE CARE UNDER “RIGHT-TO-TRY” LAW HEARD BY THE NINTH CIRCUIT COURT OF APPEALS: Cancer patients seek relief from anxiety and depression in alignment with ongoing research on the effectiveness of psilocybin in mental health care. Time: 1 p.m. PST, Thursday, September 2nd, 2021 Pasadena Virtual…

A Seattle palliative care physician, co-director of an integrative oncology clinic, and a number of his patients with advanced cancer have sued the Drug Enforcement Administration (DEA) in a case seeking to compel the DEA to allow access to psilocybin therapy for patients with serious illness under state and federal Right to Try (RTT) laws.…

Emerge Law Group is proud to represent a Seattle palliative care physician and co-director of an integrative oncology clinic, and a number of his patients with advanced cancer in a case seeking to open access to psilocybin therapy for patients with serious illness under state and federal Right to Try laws. Well known patient rights…

On behalf of terminally ill patients suffering anxiety and depression, we announce an advocacy effort to open access to psilocybin for terminally ill patients under state and federal “Right to Try” (RTT) laws. Well known patient rights advocate Kathryn Tucker, when she was Co-Chair of the Psychedelic Practice Group of Emerge Law Group and currently…

Kathryn Tucker, Special Counsel at Emerge Law Group and now Special Advocacy Advisor for the National Psychedelics Association represented her client, the Advanced Integrative Medical Science Institute (AIMS), a leading oncology clinic in Seattle, and its co-director Sunil K. Aggarwal, MD, PhD, a noted palliative care specialist, in AIMS’ novel effort to seek permission from…